New aspects of anticoagulant therapy in atrial fibrillation in patients with renal dysfunction
Atrial fibrillation (AF) and chronic kidney disease (CKD) are common and interrelated diseases, the combination of which is associated with a poor prognosis. The efficacy and safety of direct oral anticoagulants (DOACs) used to prevent thromboembolic complications of AF may depend on renal function...
Main Authors: | Zh. D. Kobalava, P. V. Lazarev, M. V. Vatsik |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2020-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4175 |
Similar Items
-
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
by: Narender Goel, et al.
Published: (2020-09-01) -
Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: Marta Popović, et al.
Published: (2021-01-01) -
New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01) -
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01) -
CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015-09-01)